![]() |
Volumn 16, Issue 7, 2008, Pages 4035-4051
|
Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands
|
Author keywords
1 Benzhydrylpiperazine; Anti obesity; Cannabinoid receptor; CB1 receptor antagonists; Piperazine; Rimonabant; SAR study
|
Indexed keywords
1 [4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL] 2 ETHYLBUTAN 1 ONE;
1 [4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL](FURAN 2 YL)METHANONE;
1 [4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL](THIOPHEN 2 YL)METHANONE;
1 [4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL]2 METHYLPROPAN 1 ONE;
1 [4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL]BUTAN 1 ONE;
1 [4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL]HEXAN 1 ONE;
1 [BIS(4 CHLOROPHENYL)METHYL] 4 (BUTYLSULFONYL)PIPERAZINE;
1 [BIS(4 CHLOROPHENYL)METHYL] 4 (ETHYLSULFONYL)PIPERAZINE;
1 [BIS(4 CHLOROPHENYL)METHYL] 4 (OCTYLSULFONYL)PIPERAZINE;
1 [BIS(4 CHLOROPHENYL)METHYL] 4 TOSYLPIPERAZINE;
4 [BIS(4 CHLOROPHENYL)METHYL] N CYCLOHEXYLPIPERAZINE 1 CARBOXAMIDE;
4 [BIS(4 CHLOROPHENYL)METHYL] N PHENYLPIPERAZINE 1 CARBOXAMIDE;
4 [BIS(4 CHLOROPHENYL)METHYL] N TERT BUTYLPIPERAZINE 1 CARBOXAMIDE;
4 [BIS(CHLOROPHENYL)METHYL] N (4 CHLOROPHENYL)PIPERAZINE 1 CARBOXAMIDE;
[4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL](CYCLOBUTYL)METHANONE;
[4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL](CYCLOHEXYL)METHADONE;
[4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL](CYCLOPENTYL)METHADONE;
[4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZIN 1 YL](CYCLOPROPYL)METHANONE;
BENZYL 4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZINE 1 CARBOXYLATE;
BUTYL 4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZINE 1 CARBOXYLATE;
CANNABINOID 1 RECEPTOR ANTAGONIST;
CANNABINOID 2 RECEPTOR;
N BENZYL 4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZINE 1 CARBOXAMIDE;
NEOPENTYL 4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZINE 1 CARBOXYLATE;
PHENYL 4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZINE 1 CARBOXYLATE;
PIPERAZINE DERIVATIVE;
RIMONABANT;
TERT BUTYL 4 [BIS(4 CHLOROPHENYL)METHYL]PIPERAZINE 1 CARBOXYLATE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UREA DERIVATIVE;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
BINDING AFFINITY;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
MALE;
NONHUMAN;
OBESITY;
RAT;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
DRUG DESIGN;
HUMANS;
LIGANDS;
MALE;
MOLECULAR STRUCTURE;
PIPERAZINES;
PROTEIN BINDING;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTOR, CANNABINOID, CB1;
RECEPTOR, CANNABINOID, CB2;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 41649118733
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2008.01.023 Document Type: Article |
Times cited : (21)
|
References (35)
|